You are here

Attruby

BridgeBio's ATTR-CM med Attruby gains traction, crushes analysts' early expectations

Fierce Pharma

Wed, 04/30/25 - 11:09 am

BridgeBio’s heart drug launch gets off to a fast start

BioPharma Dive

Thu, 02/20/25 - 11:34 am

transthyretin amyloidosis cardiomyopathy

JPM25: After BridgeBio touts 'remarkable' early uptake for its Vyndaqel rival, analysts hail Attruby's debut as a 'launch to own'

Fierce Pharma

Tue, 01/14/25 - 11:21 am

BridgeBio heart drug approved by FDA, setting up battle with Pfizer

BioPharma Dive

Sun, 11/24/24 - 05:58 pm

transthyretin amyloidosis cardiomyopathy